Form 4: Zimmer Biomet SVP Lori Winkler Reports Stock Transactions
SEC Form 4 Filing
Lori Winkler, SVP and CHRO of Zimmer Biomet Holdings, Inc., reported the vesting of restricted stock units and subsequent tax withholding.
Summary
- On April 1, 2024, Lori Winkler, SVP and CHRO of Zimmer Biomet Holdings, Inc., reported transactions involving common stock and restricted stock units (RSUs).
- Winkler vested 772 RSUs, which were adjusted due to the ZimVie Inc. spinoff in 2022.
- The company withheld 215 shares to satisfy tax obligations at a price of $130.65 per share.
- Following these transactions, Winkler directly owns 3,336 shares of Zimmer Biomet common stock.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing, so the sentiment is neutral.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common for executives at publicly traded companies. It provides transparency into the trading activities of company insiders.
Key Dates
| Date | Description |
|---|---|
| 03/01/2022 | Date of adjustments to RSUs in connection with Zimmer Biomet Holdings, Inc.'s spinoff of ZimVie Inc. |
| 04/01/2024 | Date of transaction: vesting of restricted stock units and tax withholding. |
| 04/03/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.